Nitrosoproline
Nitrosoproline represents a nitroso derivative derived from the amino acid proline. As an important chemical entity, nitrosoproline is the foundational component of PROLI/NO (also referred to as PROLINO or ProliNO) when mixed with sodium methoxide.
Chemical Properties[edit | edit source]
The nitroso group added to proline bestows nitrosoproline with distinct chemical and biological characteristics, making it functionally different from its parent molecule, proline. While proline is an essential amino acid involved in protein synthesis, nitrosoproline demonstrates potential as a nitric oxide (NO) donor.
PROLI/NO: A Notable Nitric Oxide Donor[edit | edit source]
When nitrosoproline is combined with sodium methoxide, the resulting compound is termed PROLI/NO. This amalgamation has gained attention for its ability to act as an "ultrafast" nitric oxide donor.
Mechanism of Action[edit | edit source]
The unique architecture of PROLI/NO facilitates the rapid release of nitric oxide once it interacts with biological systems. Its designation as an "ultrafast" donor is due to the near-instantaneous release of NO upon administration, distinguishing it from other NO-donating compounds.
Research and Clinical Implications[edit | edit source]
The potential applications of PROLI/NO span both research and clinical domains:
- Research Applications: In laboratory settings, PROLI/NO can serve as a tool for elucidating the various roles and mechanisms of nitric oxide within physiological and pathological processes.
- Clinical Prospects: The rapid release of NO by PROLI/NO makes it a candidate for therapeutic applications where swift NO delivery is pivotal. It's being explored for conditions that necessitate immediate vasodilation, and in scenarios where controlling and modulating NO levels can have therapeutic benefits.
Safety and Toxicology[edit | edit source]
Like all compounds, especially those with potential therapeutic utility, the safety and toxicological profile of nitrosoproline and PROLI/NO are crucial. Preliminary studies have focused on the compound's metabolic pathway and possible side effects to ensure its safety in biological systems.
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
